Searcharxiv⌕ Search

arXiv subjects

Morten Hasselstrøm Jensen

Publications and source records attributed to Morten Hasselstrøm Jensen.

2 recordsLinked to original sources

Tipping the Balance: Impact of Class Imbalance Correction on the Performance of Clinical Risk Prediction Models

Objective: ML-based clinical risk prediction models are increasingly used to support decision-making in healthcare. While class-imbalance correction techniques are commonly applied to improve model performance in settings with rare outcomes, their impact on probabilistic calibration remains insufficiently understood. This study evaluated the effect of widely used resampling strategies on both discrimination and calibration across real-world clinical prediction tasks. Methods: Ten clinical datasets spanning diverse medical domains and including 605,842 patients were analyzed. Multiple machine-learning model families, including linear models and several non-linear approaches, were evaluated. Models were trained on the original data and under three commonly used 1:1 class-imbalance correction strategies (SMOTE, RUS, ROS). Performance was assessed on held-out data using discrimination and calibration metrics. Results: Across all datasets and model families, resampling had no positive impact on predictive performance. Changes in the Receiver Operating Characteristic Area Under Curve (ROC-AUC) relative to models trained on the original data were small and inconsistent (ROS: -0.002, p<0.05; RUS: -0.004, p>0.05; SMOTE: -0.01, p<0.05), with no resampling strategy demonstrating a systematic improvement. In contrast, resampling in general degraded the calibration performance. Models trained using imbalance correction exhibited higher Brier scores (0.029 to 0.080, p<0.05), reflecting poorer probabilistic accuracy, and marked deviations in calibration intercept and slope, indicating systematic distortions of predicted risk despite preserved rank-based performance. Conclusion: In a diverse set of real-world clinical prediction tasks, commonly used class-imbalance correction techniques did not provide generalizable improvements in discrimination and were associated with degraded calibration.

q-bio.QM↗

Personalized Forecasting of Glycemic Control in Type 1 and 2 Diabetes Using Foundational AI and Machine Learning Models

Background: Accurate week-ahead forecasts of continuous glucose monitoring (CGM) derived metrics could enable proactive diabetes management, but relative performance of modern tabular learning approaches is incompletely defined. Methods: We trained and internally validated four regression models (CatBoost, XGBoost, AutoGluon, tabPFN) to predict six weekahead CGM metrics (TIR, TITR, TAR, TBR, CV, MAGE, and related quantiles) using 4,622 case-weeks from two cohorts (T1DM n=3,389; T2DM n=1,233). Performance was assessed with mean absolute error (MAE) and mean absolute relative difference (MARD); quantile classification was summarized via confusion-matrix heatmaps. Results: Across T1DM and T2DM, all models produced broadly comparable performance for most targets. For T1DM, MARD for TIR, TITR, TAR and MAGE ranged 8.5 to 16.5% while TBR showed large MARD (mean ~48%) despite low MAE. AutoGluon and tabPFN showed lower MAE than XGBoost for several targets (e.g., TITR: p<0.01; TAR/TBR: p<0.05 to 0.01). For T2DM MARD ranged 7.8 to 23.9% and TBR relative error was ~78%; tabPFN outperformed other models for TIR (p<0.01), and AutoGluon/ tabPFN outperformed CatBoost/XGBoost on TAR (p<0.05). Inference time per 1,000 cases varied markedly (PFN 699 s; AG 2.7 s; CatBoost 0.04 s, XGBoost 0.04 s). Conclusions: Week-ahead CGM metrics are predictable with reasonable accuracy using modern tabular models, but low-prevalence hypoglycemia remains difficult to predict in relative terms. Advanced AutoML and foundation models yield modest accuracy gains at substantially higher computational cost.

q-bio.OT↗